Skip to the page

Data / Form D filings / Lapix Therapeutics Inc.

Lapix Therapeutics Inc.: Form D filings

Lapix Therapeutics Inc., a technology company in Cambridge, MA, filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on August 5, 2025, reports $2.2 million sold of a $5 million offering to 10 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
271 Cambridge St., 2nd Floor, Cambridge, MA, 02141
Phone
(858) 226-4717
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1947620

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 5, 2025New notice$5,000,000$2,200,000$2,800,00010Jul 21, 2025sec.gov
Feb 10, 2025Amendment$6,000,000$5,520,946$479,05425Aug 2, 2024sec.gov
Aug 19, 2024New notice$5,499,999$2,219,990$3,280,00912Aug 2, 2024sec.gov
Apr 27, 2023New notice$14,557,480$5,947,478$8,610,00232Apr 14, 2023sec.gov
Oct 18, 2022New notice$1,500,000$1,247,500$252,5007Aug 29, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Anas FathallahExecutive Officer, Director
Anthony GibneyDirector
Jason NorrisExecutive Officer, Director
Francisco LeonDirector
Henry McKinnellDirector

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Aug 4, 2025 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Lapix Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.